Alnylam Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Alnylam Pharmaceuticals Inc
TickerALNY
CIK #0001178670
CUSIP02043Q107
SectorLife Sciences - Pharmaceutical Preparations
Address300 Third Street, Cambridge, MA 02142
Source [EDGAR]
CIK Filing 2011 - 2025
[0001178670] 10-K
[0001178670] 10-Q
[0001178670] 3
[0001178670] 4
[0001178670] 5
[0001178670] 8-K
[0001178670] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Capital Research Global Investors Alnylam Pharmaceuticals Inc [2025-02-13] 0.0
Capital World Investors Alnylam Pharmaceuticals Inc [2022-09-09] 10.7
Price T Rowe Associates Inc /MD/ Alnylam Pharmaceuticals Inc [2022-02-14] 5.4
Baillie Gifford & Co Alnylam Pharmaceuticals Inc [2020-02-03] 7.34
Price T Rowe Associates Inc /MD/ Alnylam Pharmaceuticals Inc [2017-12-11] 11.7
BlackRock Inc Alnylam Pharmaceuticals Inc [2017-01-30] 5.1
Dodge & Cox Alnylam Pharmaceuticals Inc [2016-12-09] 10.6
Vanguard Group Inc Alnylam Pharmaceuticals Inc [2016-02-10] 5.95
BlackRock Inc Alnylam Pharmaceuticals Inc [2016-01-28] 5.1
Sanofi Alnylam Pharmaceuticals Inc [2014-03-05] 12.0
Price T Rowe Associates Inc /MD/ Alnylam Pharmaceuticals Inc [2014-02-12] 6.0
Vanguard Specialized Funds Alnylam Pharmaceuticals Inc [2014-02-04] 6.47
Wellington Management Co LLP Alnylam Pharmaceuticals Inc [2013-12-10] 12.11
Alnylam Pharmaceuticals Inc Regulus Therapeutics Inc [2013-02-14] 17.2
Form 3/4/5 Filer 2011 - 2025
Alnylam Pharmaceuticals Inc
Bonney Michael W
Greenstreet Yvonne
Poulton Jeffrey V.
Fitzgerald Kevin Joseph
Tanguler Tolga
Garg Pushkal
Ausiello Dennis A
Sigal Charles Elliott
Bertozzi Carolyn R
Brandicourt Olivier
Hamburg Margaret A
Kellogg Peter N
Pyott David E I
Reitan Colleen F
Schulman Amy W
Hesslein Robert W.
Sharp Phillip A
Franchini Indrani Lall
Vaishnaw Akshay
Fanucci Marsha
Paul Steven M
Maraganore John
Keating Laurie
Greene Barry E
Schimmel Paul
Soni Manmeet Singh
Sanofi
Mason Michael
Clarke John K
Starr Kevin P
Gros David-Alexandre C
Regulus Therapeutics Inc.
Reid Laurence
Dzau Victor J
Novartis Pharma AG
Novartis AG
Form 13F Holdings
Firm Period DFND Voting Shares
Capital World Investors [2025-06-30] DFND 16,781,194 16,805,007
FMR LLC [2025-06-30] DFND 15,305,392 15,806,521
Vanguard Group Inc [2025-06-30] SOLE 0 12,947,241
BlackRock, Inc. [2025-06-30] SOLE 9,248,495 9,979,934
Capital Research Global Investors [2025-06-30] DFND 7,181,265 7,191,656
Regeneron Pharmaceuticals Inc [2025-06-30] SOLE 4,444,445 4,444,445
Dodge & Cox [2025-06-30] SOLE 3,002,221 3,197,096
State Street Corp [2025-06-30] DFND 2,560,247 3,173,105
Geode Capital Management LLC [2025-06-30] DFND 2,398,770 2,398,770
Baillie Gifford & Co [2025-06-30] DFND 2,132,268 2,267,557
Orbis Allan Gray Ltd [2025-06-30] DFND 2,121,412 2,121,412
Wellington Management Group LLP [2025-06-30] DFND 0 2,075,752
JPMorgan Chase & Co [2025-06-30] DFND 1,959,248 2,061,745
Norges Bank [2025-06-30] SOLE 2,032,680 2,032,680
American Century Companies Inc [2025-06-30] DFND 1,591,579 1,793,846
Invesco Ltd. [2025-06-30] DFND 0 1,341,694
Bank of America Corp /DE/ [2025-06-30] DFND 33,615 1,257,728
Legal & General Group Plc [2025-06-30] DFND 832,218 872,771
Northern Trust Corp [2025-06-30] DFND 823,961 830,241
Nuveen, LLC [2025-06-30] DFND 773,492 774,969
Morgan Stanley [2025-06-30] DFND 546,191 770,968
Baillie Gifford & Co [2025-06-30] SOLE 508,754 764,334
Winslow Capital Management LLC [2025-06-30] OTR 0 732,134
Citadel Advisors LLC [2025-06-30] DFND 700,799 700,799
Bellevue Group AG [2025-06-30] DFND 676,367 676,367
Woodline Partners LP [2025-06-30] SOLE 623,115 623,115
Franklin Resources Inc [2025-06-30] DFND 592,476 601,331
Macquarie Group Ltd [2025-06-30] SOLE 598,599 600,111
Holocene Advisors LP [2025-06-30] SOLE 596,816 596,816
Goldman Sachs Group Inc [2025-06-30] DFND 554,211 596,216
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com